Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Alignment Healthcare Inc’s stock clocked out at $5.18, up 3.39% from its previous closing price of $5.01. In other words, the price has increased by $3.39 from its previous closing price. On the day, 0.81 million shares were traded. ALHC stock price reached its highest trading level at $5.19 during the session, while it also had its lowest trading level at $4.915.
Ratios:
To gain a deeper understanding of ALHC’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 1.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on March 06, 2024, initiated with a Underweight rating and assigned the stock a target price of $4.50.
On March 06, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $12 to $6.
On January 24, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $11.Stifel initiated its Buy rating on January 24, 2024, with a $11 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 28 ’24 when Maroney Dawn Christine sold 10,151 shares for $4.84 per share. The transaction valued at 49,131 led to the insider holds 1,976,097 shares of the business.
Kardes Hakan sold 4,363 shares of ALHC for $21,117 on Mar 28 ’24. The Chief Experience Officer now owns 430,444 shares after completing the transaction at $4.84 per share. On Mar 28 ’24, another insider, Freeman Robert Thomas, who serves as the Chief Financial Officer of the company, sold 4,299 shares for $4.84 each. As a result, the insider received 20,807 and left with 865,407 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 978905984 and an Enterprise Value of 801589120. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.54 while its Price-to-Book (P/B) ratio in mrq is 6.24. Its current Enterprise Value per Revenue stands at 0.44 whereas that against EBITDA is -7.689.
Stock Price History:
Over the past 52 weeks, ALHC has reached a high of $9.20, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is -3.53%, while the 200-Day Moving Average is calculated to be -19.79%.
Shares Statistics:
It appears that ALHC traded 908.13K shares on average per day over the past three months and 792450 shares per day over the past ten days. A total of 188.95M shares are outstanding, with a floating share count of 90.72M. Insiders hold about 52.41% of the company’s shares, while institutions hold 42.81% stake in the company. Shares short for ALHC as of 1711584000 were 3944667 with a Short Ratio of 4.34, compared to 1709164800 on 4433922. Therefore, it implies a Short% of Shares Outstanding of 3944667 and a Short% of Float of 3.3000000000000003.
